Renier Brentjens, MD, Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center

RenierJBrentjensMD

Oncology New York, NY

Hematologic Oncology

Associate Professor, Medicine, Weill Cornell Medical College

Dr. Brentjens is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brentjens' full profile

Already have an account?

Summary

  • Dr. Renier Brentjens is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his MD and PhD degrees from University at Buffalo, School of Medicine and Biomedical Sciences, did his residency in Internal Medicine at YAle New Haven Hospital and has been in practice 21 years. He also speaks multiple languages, including Dutch. He specializes in hematologic oncology focused on Leukemia.

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Hematology/Oncology, 1998 - 2002
  • Yale-New Haven Hospital
    Yale-New Haven HospitalResidency, Internal Medicine, 1996 - 1998
  • University at Buffalo, School of Medicine and Biomedical Sciences
    University at Buffalo, School of Medicine and Biomedical SciencesClass of 1996

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1998 - 2021
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2014
  • America's Top Doctors Castle Connolly, 2014
  • Top Doctors: New York Metro Area Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
    Renier J. Brentjens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical Factors Associated with Improved Survival Following Allogeneic HSCT after CD19 CAR Therapy in Adult Patients with Relapsed B-ALL
    Renier J. Brentjens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
    Renier J. Brentjens, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL “Armored” CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Tr... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated with Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Expert Discussion and Guidance on New Advances, Clinical Opportunities, and Current Challenges in Treating Adults with Ph-Negative Acute Lymphoblastic Leukemia 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • Research Round-up: Multiple Myeloma
    Research Round-up: Multiple MyelomaNovember 26, 2020 12:10
  • Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
    Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell TherapiesNovember 19, 2020 15:41
  • CAR-T Cells Used to Target Glioblastoma
    CAR-T Cells Used to Target GlioblastomaJuly 26, 2019 00:41
  • Join now to see all

Grant Support

  • Adoptive Immunotherapy Of Cancer With IL-12 Secreting Tumor-Targeted T CellsNational Cancer Institute2009–2012
  • Genetic Targeting Of T Cells To B Cell MalignanciesNational Cancer Institute2003–2005

Professional Memberships

Other Languages

  • Dutch

Hospital Affiliations